Literature DB >> 564871

[Human catabolism of medium and long chain triglycerides after intravenous infusion].

P Jansing, H Reinauer.   

Abstract

The metabolic rate of intravenously administered middle-chain and long-chain triglycerides has been tested in metabolically healthy adult subjects. After an infusion period of three hours (infusion rate 0.22 g triglyceride/kg body-weight and hour) the metabolic rate of long-chain triglycerides was 16.4 mg/kg body-weight and hour. The metabolic rate of the middle-chain triglycerides (infusion rate 0.056 g/kg body-weight and hour) administered in a mixture with long-chain triglycerides was slower: 4.8 mg/kg body-weight and hour. Even under these conditions, middle-chain triglycerides increased ketonemia and ketonuria. Furthermore, the acetate level in blood increased significantly. Infusion of lipids have a strong effect on amino-acid levels in blood. The concentration of alanine, leucine, isoleucine are decreased, whereas the concentration of glutamate increases at the same time. Under clinical parameters only a mild leucocytosis has been found. Our data suggest that the metabolic rate of middle-chain triglycerides is according to their low plasma concentration slow, nevertheless, the ketogenesis is significantly higher if middle-chain triglycerides are infused in a mixture with long-chain triglycerides.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564871

Source DB:  PubMed          Journal:  Infusionsther Klin Ernahr        ISSN: 0378-0791


  3 in total

Review 1.  Medium-chain triglycerides (MCT) for total parenteral nutrition.

Authors:  G Wolfram
Journal:  World J Surg       Date:  1986-02       Impact factor: 3.352

2.  [Effect of orally-administered triglycerides on muscle proteolysis in the rat].

Authors:  T Kaufmann; H Reinauer
Journal:  Z Ernahrungswiss       Date:  1983-09

3.  Fat emulsions containing medium chain triglycerides in patients with sepsis syndrome: effects on pulmonary hemodynamics and gas exchange.

Authors:  P Radermacher; B Santak; H Strobach; K Schrör; J Tarnow
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.